Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

17 Apr 2008 07:00

Tarsus Group PLC17 April 2008 Tarsus Group plc ("Tarsus or "the Group") Interim Management Statement and Annual General Meeting At today's Annual General Meeting Neville Buch, the Chairman of Tarsus, willpresent the following Interim Management Statement. Tarsus is today publishing its first Interim Management Statement relating tothe period from 1 January 2008 to 16 April 2008. Trading performance The current year has begun well with the Group's trading performance for thisperiod fully up to the Board's expectations. A summary of the more significantdevelopments includes: • In the US: - a 6% increase in revenues at the February Off-Price show comparedwith the February 2007 event. • In France:- overall revenues for the period were slightly ahead of the sameperiod last year. Of particular note was the performance of the Februaryedition of the Mod'Amont clothing show, a joint venture with Premiere Vision,which produced revenues 8% higher year-on-year. • In Emerging Markets: - overall like-for-like revenues for the period more thandoubled. The fourth edition of the Chinese travel event, COTTM, finishedyesterday with revenues 35% ahead of last year and a record attendance. Acquisition There was one transaction in the period. On 3 March 2008 Tarsus announced theacquisition of 50 per cent of the share capital of Hubei Hope ExhibitionCompany Limited ('Hope') for a maximum total consideration of RMB 20 million (approximately £1.4 million). The acquisition is conditional on receiving approval by the Chinese governmentwhich is expected shortly. Hope will provide a platform for further growth inthe more developed Shanghai market and also gives Tarsus a leading position in the fast developing Central and Western Chinese markets. Financial Position There have been no significant changes to the financial position of the Groupsince the publication of the preliminary results on 3 March 2008. The Group'snet debt is currently £30.2 million (£29.0 million as at 31 December 2007), alsoin line with the Board's expectations. The Group's major currency exposure is to the US dollar. In 2008, this exposurewill be slightly higher than in 2007 as a result of Labelexpo being held in theUS. Outlook The phasing of some of the Group's major events favours the odd years and theBoard continues to be confident about the Group's prospects for 2008 withforward bookings ahead of 2007 on a like-for-like basis. The directorsanticipate a continuation of the trend of the past 3 years with double-digitlike-for-like organic revenue growth. The Group's largest event of the year- Labelexpo Americas in September - now hasover 99% of expected space revenues contracted. The French division, which isheavily second half weighted, is continuing to benefit from the sales reorganisation undertaken in 2007 and strong cost management in 2008. Forwardbookings remain solid, led by continuing strong performances from IPConvergence and Mod'Amont. The Group's medical division continues to exceed expectations. The Orlando showlater this month is on track to produce organic revenue growth of at least 30%driven by the expanded educational aspect of the event. Bookings for the August Las Vegas Off-Price exhibition are tracking ahead of the corresponding 2007event. Neville Buch, Chairman of Tarsus, commented: "We believe that the Group will continue to benefit from the migration of mediaspend towards exhibitions and the internet as well as the increasing demandfrom our customers to sell and market their products in faster growth emergingmarkets. Tarsus derives its strength from its market-leading products, an increasinglydiversified portfolio, both by sector and geography, and an experiencedmanagement team. The year has begun well and we remain confident of furtherstrong progress over the 2008/2009 cycle."For further information please contact: Tarsus Group plc: Douglas Emslie, Group Managing Director: 020 8846 2700 Media:Matthew Moth, Madano Partnership: 020 7593 4000 Investors/Analysts:Neville Harris, IRfocus: 020 7593 4015Stephen Scott, Annabel Michie, Scott Harris 020 7653 0030 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBoard Changes
9th May 20187:00 amRNSBlock Listing Six Monthly Return
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.